BRIEF RESUME

Giovanni Gorgoni is the CEO of AReSS Puglia, the regional government agency of Apulia Region for innovation in health and social care.

Currently he is also professor of Public Management at Bari LUM University, member of the executive board at EuroHealthNet (health promotion and health inequalities) and EHTEL (eHealth and telemedicine) and vice president of italian network NISAN (health clinical costing).

Previously he directed the apulian Health Department, two local health authorities and he has been facility manager, financial manager and operations manager in the healthcare sector between Rome and Milan.

SHORT RESUME

Giovanni Gorgoni, born in 1971, is an economist with university degree in Business Economics at Milan Bocconi University, master degree in Healthcare Management at Milan Bocconi School of Management and master degree in Facility Management at Rome Campus Bio-Medico University.

He’s always been working in healthcare sector with different roles: advisor, private and public manager, professor.

His professional interests are public health, health communication, healthcare management, network and pathway designing, e-Health and care intelligence.

From December 2016 up till now is Chief Executive Officer of AReSS (Agenzia Regionale Strategica per la Salute e il Sociale Puglia), the Apulia government agency for strategic planning in health and social policies and for exploration in healthcare processes and technology. During current appointment he designed and developed seven regional clinical networks (cancer, rare disease, reumatology, hematology, stroke, heart and trauma), implemented eight value-based labs for Apulian Health System (clinical networks design, health pathways design, lean healthcare, health clinical costing, outcomes measurement, service humanization, communication for health and integrated care) and established the first regional center for telemedicine.

From October 2015 to November 2016 he was Head of Department for Health Promotion, Social Welfare and Sport for All - Apulia Region, accountable for administration of health and social policies for Apulia Region with organizational connection to regional government and annual budget of early € 7,2 billions. The main result of this appointment was the whole re-engineering of regional hospital network - 13.000 beds and 60 centers.

From January 2015 to October 2015 he was CEO of Lecce Local Health Authority in Apulia (7.900 employees, 6 hospitals, 148 community care sites and 803.000 citizens).

From July 2011 to December 2014 he was CEO of BAT Local Health Authority in Apulia (3.600 employees, 5 hospitals, 48 community care sites and 390.000 citizens).

Before July 2011 he served in Lazio Health System as CFO and COO at Viterbo Local Health Authority (2000-2008) and as Chief Facility Officer at Rome/E Local Health Authority (2008-2011).

Previously - in Milan - he worked as operations manager in Humanitas Clinical Institute and as healthcare consultant in KPMG Advisory.

Currently he’s member of Executive Board of National Program for Chronic Diseases and professor in Public Management at Bari LUM University.

From February 2018 he’s included in national register of eligible Healthcare CEOs.

Anat Katz serves in Israel's Consulate General in NY as Minister, Economic and Trade Affairs, U.S. and Canada. In this capacity Anat is responsible for promoting Israeli business engagements, exports, research and development collaborations with Canada and U.S. based companies and attracting investments to Israel.

Prior to this Anat held a number of positions in the Israeli Ministry of Economy including Senior Director, Head of the Israeli Ministry of Economy and Industry's Export Control Agency, Head of the America's desk in the Foreign Trade Administration. Anat also served as the head of Israel's Trade mission in Washington D.C. and in Singapore.

In-between Anat also headed the International Affairs Division of the Israeli parliament, the Knesset, where she promoted inter-parliamentary ties between the Knesset and the Israeli parliamentarians and their foreign counterparts.

Anat holds an MBA and a B.Sc. in laws (Honors Program) from the Hebrew University in Jerusalem. She is a graduate of a directors' course administered by the Bar Ilan University, as well as of the Ministry of Economy and Industry's prestigious Cadet Course.

Anat is a certified lawyer in Israel. She is married to Tal and is a mother of two boys.

Dr. Gladman is a licensed electrical and medical engineer who was mystified by the disconnect between clinicians and technology and went on to train in medicine. He sits on the board of directors of the Mackenzie Innovation Institute and is a member of the Health Canada Scientific Advisory Committee on Digital Health Technologies.  As Chief Information Officer and Chief Medical Information Officer at Mackenzie Health, he has a leadership role in applied innovation and healthcare technology, and more than a decade of clinical practice in adult critical care medicine. He is a graduate of the University of Toronto Engineering Science program (1994), Institute of Biomedical Engineering (1997), and School of Medicine (2003). His areas of expertise include ambiently intelligent healthcare workflow automation, the Internet of Healthcare Things, electronic health record system interoperability, and clinical change management.

Dr. Hofstein came to Toronto from Israel in 2009 to assume the position of President & CEO of a newly formed organization called MaRS Innovation (recently renamed as Toronto Innovation Acceleration Partners, TIAP). At this position, Dr. Hofstein led the creation of over fifty start-up companies primarily in the healthcare space. Among the companies of primary note are Triphase, Fibrocor and Notch Therapeutics in which Dr. Hofstein has been a cofounder and a director.  In addition, Dr. Hofstein is a member of the board of several not-for-profit organizations in Quebec and Ontario.

Prior to coming to Canada, Dr. Hofstein served as the President & CEO of Hadasit (the tech transfer company of Hadassah, Jerusalem) and the chairman of Hadasit Bio Holding (a holding company listed on the Tel-Aviv Stock Exchange). One of the companies Dr. Hofstein co-founded and joined as a director is BiolineRx, an Israeli biotech company listed on NASDAQ.

Dr. Hofstein received his Ph.D. from the Weizmann Institute of Science (Rehovot, Israel) and his postdoctoral training at Harvard Medical School. Dr. Hofstein also had a long tenure in the IDF and retired as a colonel after serving in the reserve troops for over twenty years.

Dr. Bradley Strauss obtained his MD cum laude from the University of Toronto in 1982. He completed his Residency Training in Internal Medicine at the University of Toronto in 1986 and then a Clinical Fellowship in Cardiology at the University of Ottawa Heart Institute in 1988. Subsequently he was awarded a Research Fellowship from the Heart and Stroke Foundation to do research work at the world-famous Thoraxcenter in Rotterdam, the Netherlands under the supervision of Professor Patrick Serruys. During his time in Rotterdam, he obtained a PhD from Erasmus University for his work on coronary stenting and the arterial response to stenting injury.

He recently completed a 10-year term as Chief of the Schulich Heart Program and Head of the Division of Cardiology at Sunnybrook Health Sciences Centre in Toronto, Canada. He holds the Reichmann Chair in Cardiovascular Research, and is a Professor of Medicine and Professor of Laboratory Medicine and Pathobiology at the University of Toronto.

His main clinical activity is interventional cardiology. He has been active in both basic research (arterial response to injury, angiogenesis) and clinical research related to interventional research and coronary imaging. He has authored more than 200 papers and has served on the Editorial Board of 5 journals. He holds 12 patents. He has founded a company, Matrizyme Pharma, to commercialize the use of collagenase to soften the plaque in order to facilitate guidewire crossing in chronic total occlusions.  Matrizyme Pharma has completed Phase 1 and Phase 2 Clinical trials. He is one of the co-Founders of the Medvention Innovation Program at Sunnybrook Health Sciences Center.

Ms. Ayelet Karp, leads Israel’s Trade and Economic mission in Ghana and West Africa. Prior to her appointment in Ghana, Ayelet worked at the Ministry of Economy and Industry in the Strategic Planning Department, leading various projects aimed at enhancing innovation and growth of the Israeli manufacturing sector.

Ayelet is an Alumni of Israel’s prestige civil service cadets program, and holds a Master's degree in public policy as well as an BA in Psychology and Biology and MA in Synthetic Biology.

Andrea Belardinelli  is Director of the Digital Health and Innovation Sector of the Health and healthcare rights Department of the Tuscany Region.

He was Staff Coordinator of the Business Management Unit of AOU Careggi (Careggi Teaching Hospital in Florence) and Director of the Innovation, Control and Quality Area and of the Integration and Communication Area (2013-2018).

Director of Planning and Innovation Area of the Livorno Local health authority (USL 6 Livorno 2010-2013). CIO of the Arezzo Local health authority (USL8 Arezzo 2006-2009).

He has a degree in Electronic Engineering with specialization in Computer Science and Bioengineering.

From 1994 to 2006 he was a researcher at the Institute of Clinical Physiology of the National Research Council of Pisa (CNR), carrying out applied research activities, with the design and development of biomedical devices dedicated to the patient and applications of Telemedicine, also in extreme environments, both at national and international levels (Formula One World Championship - Ferrari and Toyota teams, Directorate General for Research of the European Commission, etc.). He has collaborated with many leading private companies in the field of microelectronics, automation and ICT.

He has also carried out intense teaching activities in large private companies, public bodies and italian Regions and has been invited speaker at numerous conferences and workshops.

He is patent author for industrial inventions, and software applications registered with the SIAE mark and of numerous scientific publications in biomedical field. He has received several national and international innovation awards.